Yassine HN, Solomon V, Thakral A, Sheikh-Bahaei N, Chui HC, Braskie MN, Schneider LS, Talbot K (2022) Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists
They concluded that part of a protein complex called Mediator plays a key role in making GLP-1 drugs impactful
Its a pleasant side effect
They help you feel more active, which can indirectly support weight loss
and risk of dehydration and kidney problems with persistent gastrointestinal symptoms
The treatment algorithm recommends a patient centered and individualized treatment approach with the goal to prevent diabetes-related complications and to optimize quality of life in patients with type 2 diabetes